What long-term trends can investors expect from GRDN's earnings?

Guardian Pharmacy (GRDN) has shown volatile earnings over the past three years, with a significant decline in net income and revenue in 2024. Investors should expect the following long-term trends from GRDN's earnings:

1. **Earnings Decline**: GRDN's net income has decreased from $49.66 million in 2022 to -$71.03 million in 2024, and its revenue has fallen from $908.91 million to $1.23 billion over the same period. This trend suggests a deteriorating financial performance, which could be a cause for concern for investors.
2. **Revenue Growth**: Despite the decline in net income, GRDN's total revenue has increased, indicating that the company's sales are growing. However, the negative net income in 2024 raises questions about the company's profitability and its ability to sustain revenue growth without improving profitability.
3. **Diluted EPS**: The diluted earnings per share (EPS) has been negative in 2024, which is a red flag for investors as it suggests that the company is not generating enough earnings to support its share count. This could impact investor sentiment and the stock's performance.

|code|Ticker|Name|Date|Net Income (FY) YoY|Net Income (FY)|market_code|
|---|---|---|---|---|---|---|
|GRDN|GRDN.N|Guardian Pharmacy|2022|75.31949445738897|4.9661E7|169|
|GRDN|GRDN.N|Guardian Pharmacy|2023|-24.045025271339682|3.772E7|169|
|GRDN|GRDN.N|Guardian Pharmacy|2024|-288.3165429480382|-7.1033E7|169|

|code|Ticker|Name|Date|Total Revenue (FY)|Total Revenue (FY) YoY|market_code|
|---|---|---|---|---|---|---|
|GRDN|GRDN.N|Guardian Pharmacy|2022|9.08909E8|14.75080548232989|169|
|GRDN|GRDN.N|Guardian Pharmacy|2023|1.046193E9|15.104262362898815|169|
|GRDN|GRDN.N|Guardian Pharmacy|2024|1.228409E9|17.4170540234928|169|

In conclusion, while GRDN has shown some growth in revenue, the company's earnings have declined significantly, and its profitability is currently under pressure. Investors should monitor the company's performance closely and consider the potential risks before investing.